News
Romiplostim in Newly Diagnosed or Persistent ITP
Thrombopoietin receptor agonists (TPO-RA) are now recommended for patients with newly diagnosed immune thrombocytopenia (ITP) or persistent ITP who have failed treatment with corticosteroids or intravenous immunoglobulins. The rationale for these recommendations is documented in a paper whose authors focus on, among other things, the American Society of Hematology (ASH) 2019 guidelines or the European ITP Working Group guidelines. They also summarized published data from clinical trials, real-world practice, etc., regarding the use of the…
Initial Treatment for Newly Diagnosed ITP Patients at a Glance
Treatment of Diabetes in Pregnancy with Metformin Does Not Increase the Risk of Low Birth Weight
Current Legislative Changes Relating to Medical Devices – Overview Summary in a Nutshell
What are the patients' needs during acute phase schizophrenia therapy and how to increase their adherence?
Summary of Czech Recommendations for the Diagnosis and Treatment of Schizophrenia in Children and Adolescents 2022
Efficacy and Safety of Two Pharmacokinetically-Driven Prophylactic Regimens in People with Hemophilia A
How can inosine pranobex help with viral infections?
What has clinical research on the effects of inosin pranobex revealed, and what does it mean for practice?
Comparison of the Effect of Sonic and Manual Toothbrushes on Dental Plaque and Gingivitis Control
Conferences
News from the world of medicine
All conferences
Popular this week
- Where did COVID come from? Are infected animals or a lab leak to blame for the pandemic?
- New Algorithm to Enhance Prediction of Cardiovascular Disease Risk
- Target blood pressure values in heart failure
- BENIGN DERMATOSIS OF PENIS
- Hypercalcemia may be the first sign of multiple myeloma, but not only that